CKD beats earnings expectations; Goldman Sachs reiterates Buy and raises profit forecasts

Overview

This is a commentary report issued by Goldman Sachs following CKD (6407.T), a Japanese semiconductor equipment company, releasing its fiscal year 2026 first-quarter results. The core conclusion is: the company's Q1 operating profit significantly exceeded market expectations. Although the new fiscal year guidance is already above consensus estimates, Goldman Sachs believes actual performance still has room for further upside, hence upgrading profit forecasts again and reiterating the Buy rating. The report focuses on answering two questions: whether CKD's capacity can keep up with strong demand, and whether price increases can cover cost pressures.

Core views

CKD's Q1 operating profit reached JPY 8 billion, significantly higher than Goldman Sachs' previous estimate of JPY 7 billion and LSEG StarMine SmartEstimates' JPY 6.4 billion, representing a clear beat. The company also raised its FY3/27 (fiscal year ending March 2027) operating profit guidance from JPY 24.5 billion to JPY 28.5 billion. While this is below Goldman Sachs' more aggressive prior estimate of JPY 30 billion, it exceeds the market consensus estimate of JPY 27.7 billion. Goldman Sachs argues that given the current demand environment shows no signs of weakening, and this new guidance is below the simple annualized level of Q1 actual operating profit (JPY 32 billion), it appears conservative. Based on this judgment, Goldman Sachs has once again raised its FY3/27 operating profit forecast to JPY 33 billion, above market consensus; forecasts for FY3/28 and subsequent years remain unchanged. The two issues of greatest concern in the report—"can production be delivered?" and "can prices be raised?"—are precisely the focal points most concerned by investors during the company's earnings conference call. On the capacity front, the company has formulated a manpower expansion plan focused on manufacturing personnel and has incorporated related cost increases into its forecasts. However, Goldman Sachs believes that local labor in Japan is the tightest resource besides semiconductor procurement, and execution may not be as smooth as the company expects. Internal resource reallocation over the past two quarters is expected to continue at least through the full FY3/27. A more positive factor comes from the factory side: while rapid installation of cleanrooms and equipment at the Tohoku Second Factory will take several years, most factories are currently running at full capacity with double shifts. There is still idle capacity in China, and the Hokuriku and Malaysia factories are expected to ramp up earlier than anticipated, supported by strong customer investment willingness and improved company execution. Goldman Sachs believes that the positive impact of factory capacity release on revenue growth outweighs measures simply adding manpower. On the pricing front, Goldman Sachs observes that the entire semiconductor supply chain, from upstream to downstream, is driving price increases, and CKD's pricing power is strengthening synchronously. The company uses cautious language but acknowledges that the momentum of price increases across the entire industry chain is accumulating. Goldman Sachs expects that rising manufacturing labor and procurement costs will become more pronounced in FY3/28, while the positive effect of price increases in FY3/27 alone will be sufficient to outweigh cost pressures, leading to significant improvement in cost of sales. From a financial performance perspective, fluid control-related revenue has grown by 40% since Q3 FY3/26, significantly surpassing previous highs. Goldman Sachs believes this indicates that the company underestimated its own significantly improved execution capability, which also explains why the company's guidance is generally conservative—reflecting only high-conviction catalysts without factoring in the conversion of customer inquiries. Goldman Sachs believes there is significant upside space in the current fiscal year's guidance and expects market consensus estimates to be upgraded in the near term. Valuation is another core support for the report. CKD's forecast P/E for FY3/28 is only 15.7x, significantly lower than the FA (Factory Automation) sector average of 25.1x and the machinery equipment sector average of 23.8x. Considering that over 70% of the company's profit this fiscal year comes from semiconductors and semiconductor production equipment—a structural growth area—and that CKD is a leader in global niche markets with high profitability and growth potential, Goldman Sachs believes the current valuation discount lacks sufficient justification, making the investment value attractive.

Analysis framework

Goldman Sachs' analytical thread can be summarized as "beat expectations—conservative guidance—dual-line verification of capacity and prices—valuation re-rating." Step one: compare Q1 actual operating profit with its last estimate and market consensus to confirm the magnitude of the beat; step two: compare the new fiscal year guidance with the Q1 annualized level and market consensus to determine if the guidance leaves room for upside; step three: along the lines of "can it be produced" (capacity/manpower) and "can prices be raised," break down the company's statements at the earnings call item by item and provide their own differing judgments; step four: use the proportion of semiconductor profits and relative industry valuation multiples to argue for the attractiveness of the current stock price; finally, landing on upgraded profit forecasts and maintaining the Buy target price. In terms of valuation methodology, the target price of JPY 10,000 is based on FY3/28E EV/EBITDA, using an industry average multiple of 10x with a 30% relative premium. This reflects the quantification of CKD's global niche leadership position and high profit exposure to semiconductors in the research report.

Methodology notes

• Industry/Industrial Analysis FrameworkSupply and Demand Framework

  The report shifts CKD's core contradiction from the demand side to the supply side: when demand remains strong, whether revenue can continue to grow at a high rate depends on whether capacity and manpower can keep up.

  In a supply-constrained environment, the ceiling for revenue growth is determined by supply capacity. The report judges the sustainability of revenue growth rates by assessing the pace of factory ramp-up, manpower, and procurement bottlenecks, rather than simply looking at downstream demand.

• Industry/Industrial Analysis FrameworkUpstream/Midstream/Downstream Supply Chain Transmission

  The report observes that both upstream and downstream segments of the semiconductor supply chain are driving price increases and uses this as the main basis for judging CKD's ability to raise prices.

  When the entire industry chain is in a price-increasing cycle, the bargaining environment improves for companies within the chain even if they do not actively raise prices. The report infers that CKD's price pass-through can cover cost increases using the momentum of price increases across the entire industry chain.

• Company Fundamentals and Financial FrameworkVolume-price decomposition

  The report decomposes the two factors driving revenue growth: volume growth (capacity, manpower) and price growth (price pass-through), evaluating the sustainability of each separately.

  Volume-price decomposition is a basic method for analyzing the quality of revenue growth. The report believes that opportunities on the volume side come from early factory ramp-up, while contributions on the price side come from price increases across the entire industry chain, thereby supporting sustained high revenue growth on two fronts.

• Valuation MethodEV/EBITDA valuation

  The report's target price is based on EV/EBITDA valuation, using an industry average multiple of 10x with a 30% premium.

  EV/EBITDA eliminates the impact of capital structure and non-cash depreciation, commonly used for relative valuation of manufacturing and heavy-asset companies. The report anchors CKD's target price by combining industry average multiples with a leadership premium.

• Company Fundamentals and Financial FrameworkProfit Quality Analysis

  The report uses DuPont analysis to decompose the drivers of ROE (net margin, turnover ratio, leverage) and simultaneously monitors capital return indicators such as CROCI.

  Profit quality analysis helps judge the sustainability of ROE improvement. The report's valuation table includes DuPont ROE and CROCI data, providing a basis for judging the structural improvement in the company's profitability.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• CKD (6407.T)

  The single analysis subject of the report, benefiting from strong demand for semiconductor equipment, price increases across the entire industry chain, and its own early capacity ramp-up; Goldman Sachs believes its guidance is conservative and profits have room for further upside.

  Strengths

  Leader in global niche markets; over 70% of profit this fiscal year comes from semiconductors and semiconductor production equipment; fluid control revenue grew 40% since Q3 FY3/26, significantly surpassing previous highs; Hokuriku and Malaysia factories expected to ramp up early, with still idle capacity in China.

  Weaknesses

  Local manufacturing manpower in Japan is the tightest resource besides semiconductors; the difficulty of expanding manpower may be higher than company expectations; capacity release at the Tohoku Second Factory will take several years; rising labor and procurement costs will be more pronounced after FY3/28.

  Comparison

  FY3/28 P/E of 15.7x, significantly lower than the FA sector average of 25.1x and machinery equipment sector average of 23.8x, with a obvious valuation discount; it is the FA company with the highest semiconductor profit exposure within the coverage scope.

  Risks

  Semiconductor demand weaker than expected; significant rise in input costs; fixed costs rising faster than expected.

Key data

• Q1 Operating ProfitJPY 8 billionHigher than Goldman Sachs' estimate of JPY 7 billion and market expectation of JPY 6.4 billion, clearly beating expectations
• FY3/27 Operating Profit Guidance (New)JPY 28.5 billionRaised from JPY 24.5 billion, above market consensus estimate of JPY 27.7 billion, but below Goldman Sachs' prior estimate of JPY 30 billion
• Goldman Sachs FY3/27 Operating Profit Forecast (Upgraded)JPY 33 billionRaised from JPY 30 billion to JPY 33 billion, above market consensus; forecasts for FY3/28 and thereafter remain unchanged
• FY3/28 Forecast P/E15.7xSignificantly lower than the FA sector average of 25.1x and machinery equipment sector average of 23.8x
• Proportion of Semiconductor-Related ProfitsOver 70% (this fiscal year)Goldman Sachs' estimated semiconductor profit exposure, the core support for valuation re-rating
• 12-Month Target Price¥10,000Based on FY3/28E EV/EBITDA, using industry average multiple of 10x + 30% premium
• Current Share Price and Implied Upside¥6,170 / +62.1%Implied gain of target price relative to current share price
• Fluid Control Revenue Growth Rate (since Q3 FY3/26)+40%Significantly surpassing previous highs; Goldman Sachs believes the company underestimated the improvement in its execution capability

Impact & implications

The report believes that CKD's Q1 beat and guidance upgrade confirm the continued strength of semiconductor equipment demand, and the conservatism of the company's guidance恰恰 (precisely) indicates that actual performance still has upside elasticity. Based on this, Goldman Sachs has upgraded profit forecasts and expects market consensus estimates to be adjusted upward in the near term, potentially bringing a positive reaction to the stock price. From a longer-term perspective, with over 70% of CKD's profits coming from semiconductors—a structural growth area—and its position as a global niche leader, the current discounted valuation is likely to converge as earnings continue to be upgraded. It should be noted that capacity ramp-up (especially regarding local Japanese manpower and semiconductor procurement) is the key variable for whether revenue growth rates can be maintained.

Risks

• Semiconductor demand weaker than expected, potentially weakening revenue growth momentum
• Significant rise in input costs, potentially squeezing profit margins
• Fixed costs rising faster than expected, affecting earnings elasticity
• Bottlenecks in local Japanese manpower and semiconductor procurement may constrain the pace of capacity ramp-up

What to watch

• The pace of capacity ramp-up starting from Q2, especially the progress of capacity release at Hokuriku and Malaysia factories
• Whether the momentum of price increases across the entire industry chain can continue to transmit to CKD and cover rising labor and procurement costs
• Whether market consensus estimates will be upgraded in the near term as Goldman Sachs predicts
• Changes in the company's order conversion rate, i.e., whether customer inquiries can steadily convert into actual orders and sales